Langers, a 65 year-old California-based juice brand, has debuted its first GLP-1 support beverage
In its lawsuit, the OFA said that the FDAs decision to end the shortage was a reckless and arbitrary move and could deprive patients of a vital treatment for type 2 diabetes and obesity. In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit is a precedent in this area. Prior to the OFA suit, no one has ever challenged the FDAs decision to remove a therapy from the drug shortage list. The OFA case is still ongoing, with the next court update due on Thursday
Siskind, D
This therapy has gained attention for its ability to aid in injury repair, especially in athletes or individuals dealing with joint, muscle, or tendon injuries
It works by increasing blood flow to the scalp, which helps stimulate hair follicles and promote hair growth